The Biden administration is working to expand monkeypox testing capabilities beyond a narrow group of public health labs, as infectious disease experts are now suggesting that testing for the virus needs to become part of routine care.
As the Epoch Times notes, Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky said during a conference call on Friday that her agency is working with the Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS) to expand testing capacity to include commercial laboratories.
At present, monkeypox testing is done through a network of 69 public health laboratories, which send results to the CDC for confirmation.
So far, there have been 50 confirmed cases in the US across 16 states, while roughly 300 monkeypox tests have been administered.
“There is not enough testing going on now for monkeypox in the United States,” said Dr. Tom Inglesby, director of the Johns Hopkins Center for Health Security. “The commercial labs are used to working with healthcare providers from across the country, moving samples around quickly, reporting results quickly in a way that providers understand and expect.”
Meanwhile, as Off-Guardian notes, Monkeypox hysteria continues – with The Atlantic publishing a recent piece suggesting that Monkeypox “Could be nothing,” or “Could Be the Next Syphilis.”
Nature asks, “can the global outbreaks be contained?”
The Depopulation Agenda Plan is commencing…
Please repent, carry your cross daily and accept the free gift of Jesus Christ’s Death on the Cross for payment for your sins.
#Yahweh #Yeshua #HolySpirit #LordAlmighty #SovereignLord #Nameaboveallnames #TheWay #TheTruth #TheLife #TheGate #Heaven #KingdomofHeaven #Saved #Glorified #Endtimes #LastDays #FeastofTrumpets #markofthebeast #verseoftheday #birthpains #Judgement #Christian #Christianity #hope #love #Jesus #Christ